Long term efficacy and safety of omalizumab in patients with allergic asthma-A real life study

被引：1

作者：

Papaioannou, Andriana ^{[1
]}

Mplizou, Myrto ^{[1
]}

Porpodis, Konstantinos ^{[2
]}

Fouka, Evangelia ^{[2
]}

Zervas, Eleftherios ^{[3
]}

Samitas, Konstantinos ^{[3
]}

Markatos, Miltiadis

Papiris, Spyridon ^{[1
]}

Gaga, Mina ^{[3
]}

Papakosta, Despoina ^{[2
]}

Loukides, Stelios ^{[1
]}

机构：

[1] Attikon Hosp, Resp Med Dept 2, Athens, Greece

[2] Aristotle Univ Thessaloniki, Resp Med Dept, G Papanikolaou Hosp, Thessaloniki, Greece

[3] Sotiria Hosp, Resp Med Dept 7, Athens, Greece

来源：

EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷

关键词：

Asthma; -; management; Pharmacology; Severe asthma;

D O I：

10.1183/13993003.congress-2020.2226

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

2226

引用

页数：2

共 50 条

[41] Asthma iN children: omalizumab in real-life in spain (ANCHORS study). omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma
Nieto Garcia, A.
Garriga Baraut, T.
Plaza Martin, A. M.
Nieto Cid, M.
Torres Borrego, J.
Folque Gimenez, M. M.
Lozano Blasco, J.
Bosque Garcia, M.
Moreno Galarraga, L.
Tortajada Girbes, M.
Rivas Juesas, C.
Penin Anton, M.
Caballero Rabasco, M. A.
Gaboli, M.
Lopez Neyra, A.
Navarro Moron, J.
Freixa, A.
Valdesoiro Navarrete, L.
Ballester Asensio, E.
Sanz Santiago, V
Romero Garcia, R.
Diaz De Atauri, Gimeno A.
Valenzuela Soria, A.
Sanchez Mateos, M.
Batlles Garrido, J.
Andres Martin, A.
Campos Alonso, E.
Aragon Fernandez, C.
Vazquez Rodriguez, E.
Martinez Pardo, L.
Del Rio Camacho, G.
Mazon Ramos, A.
ALLERGY, 2021, 76 : 168 - 169
[42] Real life experience of omalizumab on selected children with severe allergic asthma
Abusamra, Rania
Latham, Sarah
Chakraborty, Shrabani
Woodman, Marc
Bossley, Cara
Ruiz, Gary
Gupta, Atul
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[43] Safety and Efficacy of Allergen Immunotherapy in the Treatment of Allergic Rhinitis and Asthma in Real Life
Zeldin, Yuri
Weiler, Zeev
Magen, Eli
Tiosano, Liran
Kidon, Mona I.
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (12): : 869 - 872
[44] "Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma
Al-Ahmad, Mona
Arifhodzic, Nermina
Nurkic, Jasmina
Maher, Ahmed
Rodriguez-Bouza, Tito
Al-Ahmed, Nasser
Sadek, Ali
Jusufovic, Edin
MEDICAL PRINCIPLES AND PRACTICE, 2018, 27 (03) : 260 - 266
[45] Real-Life Safety and Efficacy of Omalizumab in Japanese Patients with Severe Allergic Asthma Subjected to Dosing Table Revision or Expansion: A Post-Marketing Survey
Asano, K.
Sumi, K.
Yoshisue, H.
Nakamura, N.
Nagasaki, M.
Sasajima, T.
Matsumoto, H.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[46] Omalizumab, an anti-IgE monoclonal antibody, demonstrates long-term asthma control, safety and tolerability in patients with severe allergic asthma
Hébert, J
Rolli, M
Gao, J
Reisner, C
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S9 - S9
[47] Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma
Berger, W
Gupta, N
McAlary, M
Fowler-Taylor, A
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (02) : 182 - 188
[48] Omalizumab is effective in the long-term control of severe allergic asthma
Lanier, BQ
Corren, J
Lumry, W
Liu, J
Fowler-Taylor, A
Gupta, N
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (02) : 154 - 159
[49] Assesment of long-term omalizumab treatment in severe allergic asthma
Ozgur, Eylem Sercan
Ozge, Cengiz
Ilvan, Ahmet
Nayci, Sibel Atis
EUROPEAN RESPIRATORY JOURNAL, 2012, 40
[50] Improvement in quality of life with omalizumab in patients with severe allergic asthma
Chipps, Bradley
Buhl, Roland
Beeh, Kai-Michael
Fox, Howard
Thomas, Karen
Reisner, Colin
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (11) : 2201 - 2208

← 1 2 3 4 5 →